{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:26:47Z","timestamp":1784716007578,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03885-2","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T17:58:58Z","timestamp":1763402338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Designing a web-based platform for dynamic estimation of individualized conditional survival in grade 3 gliomas"],"prefix":"10.1007","volume":"16","author":[{"given":"Zhihao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina Chizi","family":"Tunje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajie","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenjun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"3885_CR1","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1245\/s10434-016-5222-3","volume":"23","author":"F Pessina","year":"2016","unstructured":"Pessina F, Navarria P, Cozzi L, Ascolese AM, Simonelli M, Santoro A, Tomatis S, Riva M, Fava E, Scorsetti M, Bello L. Value of surgical resection in patients with newly diagnosed grade III glioma treated in a multimodal approach: Surgery, chemotherapy and radiotherapy. Ann Surg Oncol. 2016;23:3040\u20136.","journal-title":"Ann Surg Oncol"},{"key":"3885_CR2","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1002\/cam4.2164","volume":"8","author":"JH Fang","year":"2019","unstructured":"Fang JH, Lin DD, Deng XY, Li DD, Sheng HS, Lin J, Zhang N, Yin B. Epidemiological trends, relative survival, and prognosis risk factors of WHO grade III gliomas: A population-based study. Cancer Med. 2019;8:3286\u201395.","journal-title":"Cancer Med"},{"key":"3885_CR3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.radonc.2007.10.008","volume":"85","author":"NG Burnet","year":"2007","unstructured":"Burnet NG, Lynch AG, Jefferies SJ, Price SJ, Jones PH, Antoun NM, Xuereb JH, Pohl U. High grade glioma: imaging combined with pathological grade defines management and predicts prognosis. Radiother Oncol. 2007;85:371\u20138.","journal-title":"Radiother Oncol"},{"key":"3885_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.23736\/S1824-4785.18.03096-0","volume":"62","author":"A Pellerino","year":"2018","unstructured":"Pellerino A, Franchino F, Soffietti R, Ruda R. Overview on current treatment standards in high-grade gliomas. Q J Nucl Med Mol Imaging. 2018;62:225\u201338.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"3885_CR5","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.2174\/0929867311320260011","volume":"20","author":"G Frosina","year":"2013","unstructured":"Frosina G. Development of therapeutics for high grade gliomas using orthotopic rodent models. Curr Med Chem. 2013;20:3272\u201399.","journal-title":"Curr Med Chem"},{"key":"3885_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1568009618666180530090922","volume":"19","author":"X Zhang","year":"2019","unstructured":"Zhang X, Zhang W, Mao XG, Cao WD, Zhen HN, Hu SJ. Malignant intracranial high grade glioma and current treatment strategy. Curr Cancer Drug Targets. 2019;19:101\u20138.","journal-title":"Curr Cancer Drug Targets"},{"key":"3885_CR7","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1002\/cncr.32328","volume":"125","author":"DJ Cote","year":"2019","unstructured":"Cote DJ, Ostrom QT, Gittleman H, Duncan KR, CreveCoeur TS, Kruchko C, Smith TR, Stampfer MJ, Barnholtz-Sloan JS. Glioma incidence and survival variations by county-level socioeconomic measures. Cancer. 2019;125:3390\u2013400.","journal-title":"Cancer"},{"key":"3885_CR8","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1001\/jamaoncol.2018.1789","volume":"4","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Cote DJ, Ascha M, Kruchko C, Barnholtz-Sloan JS. Adult glioma incidence and survival by race or ethnicity in the united States from 2000 to 2014. JAMA Oncol. 2018;4:1254\u201362.","journal-title":"JAMA Oncol"},{"key":"3885_CR9","doi-asserted-by":"publisher","first-page":"748061","DOI":"10.3389\/fonc.2021.748061","volume":"11","author":"D Lin","year":"2021","unstructured":"Lin D, Wang M, Chen Y, Gong J, Chen L, Shi X, Lan F, Chen Z, Xiong T, Sun H, Wan S. Trends in intracranial glioma incidence and mortality in the united States, 1975\u20132018. Front Oncol. 2021;11:748061.","journal-title":"Front Oncol"},{"key":"3885_CR10","doi-asserted-by":"publisher","first-page":"200838","DOI":"10.1016\/j.omton.2024.200838","volume":"32","author":"Q Jiang","year":"2024","unstructured":"Jiang Q, Yang X, Deng T, Yan J, Guo F, Mo L, An S, Huang Q. Comprehensive machine learning-based integration develops a novel prognostic model for glioblastoma. Mol Ther Oncol. 2024;32:200838.","journal-title":"Mol Ther Oncol"},{"key":"3885_CR11","doi-asserted-by":"publisher","first-page":"1546530","DOI":"10.3389\/fendo.2025.1546530","volume":"16","author":"GJ Lu","year":"2025","unstructured":"Lu GJ, Zhao Y, Huang R. Identification of the high-risk population facing early death in older patients with primary intracranial glioma: a retrospective cohort study. Front Endocrinol (Lausanne). 2025;16:1546530.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3885_CR12","doi-asserted-by":"publisher","first-page":"106957","DOI":"10.1016\/j.ejso.2023.06.009","volume":"49","author":"X Meng","year":"2023","unstructured":"Meng X, Chang X, Qin P, Li Y, Guo Y. Risk-dependent conditional survival analysis and annual hazard rate of inflammatory breast cancer. Eur J Surg Oncol. 2023;49:106957.","journal-title":"Eur J Surg Oncol"},{"key":"3885_CR13","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1001\/jamaoncol.2018.2895","volume":"4","author":"CR Thomas Jr","year":"2018","unstructured":"Thomas CR Jr. Conditional survival as a pragmatic resource for cancer survivors and health care professionals. JAMA Oncol. 2018;4:1130\u20131.","journal-title":"JAMA Oncol"},{"key":"3885_CR14","doi-asserted-by":"publisher","first-page":"e2342270","DOI":"10.1001\/jamanetworkopen.2023.42270","volume":"6","author":"TI Yoon","year":"2023","unstructured":"Yoon TI, Jeong J, Lee S, Ryu JM, Lee YJ, Lee JY, Hwang KT, Kim H, Kim S, Lee SB, et al. Survival outcomes in premenopausal patients with invasive lobular carcinoma. JAMA Netw Open. 2023;6:e2342270.","journal-title":"JAMA Netw Open"},{"key":"3885_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s12672-023-00839-4","volume":"14","author":"Y Shi","year":"2023","unstructured":"Shi Y, Zheng Y, Zhang H, Dong W, Zhang P. Dynamic estimates of survival in oncocytic cell carcinoma of the thyroid. Discov Oncol. 2023;14:217.","journal-title":"Discov Oncol"},{"key":"3885_CR16","doi-asserted-by":"publisher","first-page":"1443157","DOI":"10.3389\/fmed.2024.1443157","volume":"11","author":"L Xu","year":"2024","unstructured":"Xu L, Yang Z, Chen H, Sun C, Tu C, Gu Z, Luo M. Conditional survival and changing risk profile in patients with gliosarcoma. Front Med (Lausanne). 2024;11:1443157.","journal-title":"Front Med (Lausanne)"},{"key":"3885_CR17","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s12672-024-01275-8","volume":"15","author":"C Sun","year":"2024","unstructured":"Sun C, Yang Z, Gu Z, Huang H. Conditional survival estimates for ependymomas reveal the dynamic nature of prognostication. Discov Oncol. 2024;15:460.","journal-title":"Discov Oncol"},{"key":"3885_CR18","doi-asserted-by":"publisher","first-page":"1356947","DOI":"10.3389\/fonc.2024.1356947","volume":"14","author":"G Zheng","year":"2024","unstructured":"Zheng G, Yang Z, Qian H, Huang H, Gu Z. Conditional survival of patients with primary bone lymphoma of the spine: how survival changes after initial diagnosis. Front Oncol. 2024;14:1356947.","journal-title":"Front Oncol"},{"key":"3885_CR19","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1182\/blood.2024027287","volume":"145","author":"JC Hernandez-Boluda","year":"2025","unstructured":"Hernandez-Boluda JC, Mosquera-Orgueira A, Gras L, Koster L, Tuffnell J, Kroger N, Gambella M, Schroeder T, Robin M, Sockel K, et al. Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis. Blood. 2025;145:3139\u201352.","journal-title":"Blood"},{"key":"3885_CR20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2340\/1651-226X.2025.42994","volume":"64","author":"N Groes Kofoed","year":"2025","unstructured":"Groes Kofoed N, Falconer H, Bottai M, Salehi S. The trajectory of conditional, recurrence-free, and long-term survival in a complete 10-year cohort of patients with advanced ovarian cancer. Acta Oncol. 2025;64:423\u201330.","journal-title":"Acta Oncol"},{"key":"3885_CR21","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than Meets the eye. Lancet Oncol. 2015;16:e173\u2013180.","journal-title":"Lancet Oncol"},{"key":"3885_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S1470-2045(16)30598-8","volume":"18","author":"RL Meyers","year":"2017","unstructured":"Meyers RL, Maibach R, Hiyama E, Haberle B, Krailo M, Rangaswami A, Aronson DC, Malogolowkin MH, Perilongo G, von Schweinitz D, et al. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the children\u2019s hepatic tumors international collaboration. Lancet Oncol. 2017;18:122\u201331.","journal-title":"Lancet Oncol"},{"key":"3885_CR23","doi-asserted-by":"publisher","first-page":"100877","DOI":"10.1016\/j.xcrm.2022.100877","volume":"4","author":"JM Bader","year":"2023","unstructured":"Bader JM, Deigendesch N, Misch M, Mann M, Koch A, Meissner F. Proteomics separates adult-type diffuse high-grade gliomas in metabolic subgroups independent of 1p\/19q codeletion and across IDH mutational status. Cell Rep Med. 2023;4:100877.","journal-title":"Cell Rep Med"},{"key":"3885_CR24","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1200\/JCO.24.00049","volume":"43","author":"SEO Kacimi","year":"2025","unstructured":"Kacimi SEO, Dehais C, Feuvret L, Chinot O, Carpentier C, Bronnimann C, Vauleon E, Djelad A, Cohen-Jonathan Moyal E, Langlois O, et al. Survival outcomes associated with First-Line Procarbazine, CCNU, and vincristine or Temozolomide in combination with radiotherapy in IDH-Mutant 1p\/19q-Codeleted grade 3 oligodendroglioma. J Clin Oncol. 2025;43:329\u201338.","journal-title":"J Clin Oncol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03885-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03885-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03885-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T06:40:40Z","timestamp":1763448040000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03885-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3885"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03885-2","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"19 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2111"}}